Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

August 3, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Non-small Cell Lung Cancer
Trial Locations (25)

12002

H. Provincial de Castellón, Castelló

23007

Hospital de Jaén, Jaén

27003

Hospital Lucus Agustí, Lugo

28035

H.U. Puerta de Hierro, Madrid

28911

Hospital Severo Ochoa, Leganés

29603

Hospital Costa del Sol, Marbella

31008

Clínica Universitaria de Navarra, Pamplona

35016

Complejo Hospitalario Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria

37007

Hospital Clinico de Salamanca, Salamanca

38010

Hospital Nuestra Señora Candelaria, Santa Cruz de Tenerife

43003

Hospital Sant Pau i Santa Tecla, Tarragona

46014

H. General U. de Valencia, Valencia

46017

Hospital Dr. Peset, Valencia

46500

Hospital de Sagunto, Valencia

46600

Hospital Universitario de la Ribera, Alzira

03202

Hospital de Elche, Elche

03186

Hospital de Torrevieja, Torrevieja

08916

ICO-Badalona, Badalona

08190

Hospital General de Catalunya, Sant Cugat del Vallès

08220

Consorci Sanitari de Terrassa, Terrassa

07198

Hospital Son Llàtzer, Palma de Mallorca

03010

H.G.U. Alicante, Alicante

08028

Hospital Universitari Quirón Dexeus, Barcelona

08041

Hospital de La Santa Creu I Sant Pau, Barcelona

Unknown

H. Clínico San Carlos, Madrid

All Listed Sponsors
lead

Spanish Lung Cancer Group

OTHER

NCT03156868 - Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma | Biotech Hunter | Biotech Hunter